Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.44M | -23.00M | -19.23M | -1.21M | -15.27M |
| Total Depreciation and Amortization | 37.00K | 39.00K | 371.00K | 372.00K | 362.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 668.00K | 4.86M | 833.00K | 1.29M | 898.00K |
| Change in Net Operating Assets | -1.54M | 1.45M | 1.18M | -2.05M | -2.17M |
| Cash from Operations | -18.27M | -16.66M | -16.84M | -1.60M | -16.18M |
| Capital Expenditure | -4.00K | -56.00K | -1.00K | -4.00K | -594.00K |
| Sale of Property, Plant, and Equipment | -- | 222.00K | 29.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.72M | 7.58M | 17.09M | 2.33M | 26.76M |
| Cash from Investing | 28.71M | 7.74M | 17.12M | 2.32M | 26.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.00K | 172.00K | 0.00 | 141.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.00K | 172.00K | 0.00 | 141.00K | -- |
| Foreign Exchange rate Adjustments | 7.00K | -11.00K | 4.00K | 6.00K | -34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.47M | -8.76M | 284.00K | 872.00K | 9.95M |